Lantronix, Inc. LTRX
Lantronix is a buy on a turnaround that is gaining real traction. FY2026 (ended June 30, 2026) showed the operating loss narrowing to $3.7M from $11.0M in FY2025, total debt eliminated to zero from $21.2M, and free cash flow growing to $9.3M from $6.8M, while Q4 revenue of $31.2M grew 8% YoY with positive EPS of $0.04.
FY2027 guidance for projected annualized EPS of $0.20 and accelerating revenue, combined with the debt-free balance sheet and strategic positioning in NDAA-compliant unmanned systems, supports an upgrade from hold despite the stock trading below both its 50-day MA of $5.73 and 200-day MA of $5.99.
What could go wrong
- Technical weakness. Stock at $5.37 trades below both its 50-day MA of $5.73 and 200-day MA of $5.99 with a negative MACD histogram of -0.064 and RSI of 42, suggesting near-term selling pressure has not fully cleared.
- Minimal institutional conviction. Smart money score of 0.0009 across 30 funds as of the quarter ended 2026-06-30 remains very low, and 24-month net insider selling of 2.4M shares suggests limited confidence from sophisticated investors.
- Full-year revenue still declining. FY2026 revenue of $120.9M is below FY2025's $122.9M, with revenue growth of -0.0165 YoY, so the Q4 acceleration has not yet translated to full-year growth.
- Guidance execution risk. FY2027 guidance for annualized EPS of $0.20 (per Seeking Alpha) implies a significant step-up from FY2026's diluted EPS of -$0.11, and any miss could reset sentiment sharply given the low institutional base.
What would change my mind
Where this comes from: FMP annual fundamentals, fiscal years 2026 and 2025 · MarketBeat and Zacks news articles, 2026-08-26 · Seeking Alpha news article, 2026-08-28 · Technical data as of 2026-08-28. Orin's read on LTRX; not advice.
Twelve months actual closes to 2026-09-23 · actual filings
50-day average 200-day average · volume below
On file
All LTRX filingsLargest holders · 13F Q2 2026
Money flow| Filer | Position | Of fund |
|---|---|---|
| Vanguard Capital Management | $9.1M | 0.0% of fund |
| State Street | $8.1M | 0.0% of fund |
| AWM Investment Company | $7.3M | 0.6% of fund |
| Geode Capital Management | $5.3M | 0.0% of fund |
| Two Sigma Investments | $4.9M | 0.0% of fund |
| Citadel Advisors | $4.6M | 0.0% of fund |
33 filers · quarter ended Q2 2026 · positions, not flows
Insiders, last 24 months: 266 Form 4 filings, net −$1.8M. Of the 50 on hand, 1 was an open-market purchase and 0 sales— the rest are grants, option exercises and tax withholding.
Ask Orin about LTRX
Orin answers questions about LTRX from its filings, transcripts and numbers — with the source behind every claim. Your own desk starts with 3 free days, card required.
Start 3 free days →Where it trades
| Metric | Now | Own median | Sector |
|---|---|---|---|
| P/S | 2.36× | — | — |
| P/B | 2.3× | — | — |
13.6%
free-cash-flow growth every year for 10 years, discounted at 10%, is what today’s price implies — starting from $0.0B of trailing free cash flow. It is an assumption the market is making, not a forecast Orin is making.
What Wall Street published
$11
$10 – $11 · +66% against today's price
- 6 buy or overweight
- 0 hold
- 0 underweight or sell
The analysts’ consensus and their own ratings, not Orin’s. A target is a twelve-month opinion published by the firm that wrote it.
Against the companies it is compared to
| Company | Market cap | P/E | EV/EBITDA | Gross | Net | ROE |
|---|---|---|---|---|---|---|
| LTRXLantronix, Inc. | $285M | — | — | 42.7% | -3.5% | -5% |
| AXTIAXT, Inc. | $4B | — | 231.1× | 32.2% | 3.2% | 1% |
The median is of the 1 peers listed above and nothing else — check it against the column. The peer set is the vendor’s, so a company can appear here that a person would not have chosen.
What it has traded at
What its sector has traded at
Two scales, drawn separately on purpose: a sector median and one company’s multiple are not the same number and putting them on one axis invites a comparison neither series supports.
Every estimate on one scale
The vertical rule is the current price. Ranges and point estimates are the backend’s, published as they were calculated; an arrow means the estimate sits beyond this scale, and its number is on the right.